Nataline Meinhardt
Overview
    Explore the profile of Nataline Meinhardt including associated specialties, affiliations and a list of published articles.
          
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              4
            
            
              Citations
              114
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          Published In
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Schuler K, Kodukulla M, Rosenblum C, Meinhardt N, Sellnow R, Parker T
  
  
    Curr Med Res Opin
    . 2022 May;
          38(6):875-880.
    
    PMID: 35593160
  
  
          Recent increases in the practice of parallel publication, during which a peer-reviewed manuscript is published concurrently with the first dissemination of the same key data at a medical congress as...
      
2.
        
    
    Goldberg J, Chen X, Meinhardt N, Greenbaum D, Petersson E
  
  
    J Am Chem Soc
    . 2014 Jan;
          136(5):2086-93.
    
    PMID: 24472041
  
  
          Thioamide quenchers can be paired with compact fluorophores to design "turn-on" fluorescent protease substrates. We have used this method to study a variety of serine-, cysteine-, carboxyl-, and metallo-proteases, including...
      
3.
        
    
    Jo H, Meinhardt N, Wu Y, Kulkarni S, Hu X, Low K, et al.
  
  
    J Am Chem Soc
    . 2012 Sep;
          134(42):17704-13.
    
    PMID: 22998171
  
  
          We have designed a highly specific inhibitor of calpain by mimicking a natural protein-protein interaction between calpain and its endogenous inhibitor calpastatin. To enable this goal we established a new...
      
4.
        
    
    Velmourougane G, Harbut M, Dalal S, McGowan S, Oellig C, Meinhardt N, et al.
  
  
    J Med Chem
    . 2011 Mar;
          54(6):1655-66.
    
    PMID: 21366301
  
  
          The malarial PfA-M1 metallo-aminopeptidase is considered a putative drug target. The natural product dipeptide mimetic, bestatin, is a potent inhibitor of PfA-M1. Herein we present a new, efficient, and high-yielding...